Celeste M. Karch, Ph.D.

Washington University, Saint Louis, St. Louis, MO 
"Celeste Karch"
Mean distance: 16.38 (cluster 31)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Finsterwalder S, Vlegels N, Gesierich B, et al. (2020) Small vessel disease more than Alzheimer's disease determines diffusion MRI alterations in memory clinic patients. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Schultz SA, Strain JF, Adedokun A, et al. (2020) Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease. Neurobiology of Disease. 104960
Barthélemy NR, Li Y, Joseph-Mathurin N, et al. (2020) A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease. Nature Medicine. 26: 398-407
Hsu S, Pimenova AA, Hayes K, et al. (2020) Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2. Neurobiology of Disease. 104817
Franzmeier N, Koutsouleris N, Benzinger T, et al. (2020) Predicting sporadic Alzheimer's disease progression via inherited Alzheimer's disease-informed machine-learning. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Aschenbrenner AJ, James BD, McDade E, et al. (2020) Awareness of genetic risk in the Dominantly Inherited Alzheimer Network (DIAN). Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 16: 219-228
Karch CM, Kao AW, Karydas A, et al. (2019) A Comprehensive Resource for Induced Pluripotent Stem Cells from Patients with Primary Tauopathies. Stem Cell Reports
Dube U, Del-Aguila JL, Li Z, et al. (2019) An atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associations. Nature Neuroscience
Deming Y, Filipello F, Cignarella F, et al. (2019) The gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk. Science Translational Medicine. 11
Hernandez I, Luna G, Rauch JN, et al. (2019) A farnesyltransferase inhibitor activates lysosomes and reduces tau pathology in mice with tauopathy. Science Translational Medicine. 11
See more...